CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1000
-0.0050 (-4.76%)
At close: Nov 4, 2026
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $2.06 million as of November 5, 2026. It is the 47,867th most valuable company in the world and the 6,372nd biggest in the United States. Its market cap has decreased by 90.45% in one year.
Market Cap
2.06M
Enterprise Value
38.79M
Revenue
20.11M
Global Rank
Country Rank
#6,372 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from 101.76M to 2.06M, a decrease of -97.98%. That is a compound annual growth rate of -12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 2.06M | -88.23% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 2.62M |
| GPL Holdings | 2.56M |
| Vaccinex | 2.41M |
| America Great Health | 2.12M |
| Nymox Pharmaceutical | 2.10M |
| AccuStem Sciences | 2.09M |
| Emmaus Life Sciences | 1.92M |
| Vaxxinity | 1.90M |